Skip to main content
A

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Filings indexed 1,284 across all filing types
Latest filing 2024-10-11 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
独立董事候选人声明与承诺-顾军
Regulatory Filings
2024-10-11 Chinese
独立董事候选人声明与承诺-袁华刚
Regulatory Filings
2024-10-11 Chinese
安图生物第四届董事会第十八次会议决议公告
Regulatory Filings
2024-10-11 Chinese
安图生物子公司管理制度
Regulatory Filings
2024-10-11 Chinese
安图生物董事会提名委员会关于董事会换届选举董事候选人的审查意见
Regulatory Filings
2024-10-11 Chinese
安图生物第四届监事会第十六次会议决议公告
Regulatory Filings
2024-10-11 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.